OrthoSpace

Company Overview

Snapshot

Founded in March 2009, OrthoSpace operated with 11–50 employees and raised $17.6M across 3 funding rounds from 4 investors. The company was acquired by Stryker Corporation in March 2019.

Business overview

OrthoSpace is a Health Tech & Life Sciences company focused on developing and commercializing simple-to-implant biodegradable balloon systems for the orthopedic market. Its core product, InSpace, is an implantable, biodegradable balloon system designed as an alternative treatment for irreparable rotator cuff tears. The system aims to reduce pain and increase patients' range of motion by creating a space between bones to alleviate friction, thereby shortening rehabilitation periods. OrthoSpace serves the healthcare industry, targeting patients and providers with medical devices and biomaterials for medical treatment and therapeutics.

Strategic signal

OrthoSpace's acquisition by Stryker Corporation in March 2019 for $220 million highlights the strategic value of its InSpace biodegradable balloon system within the orthopedic medical device market. This exit demonstrates strong validation of OrthoSpace's technology and its potential to address significant unmet needs in rotator cuff repair, signaling a successful development and commercialization pathway for innovative medical solutions.

Company Intelligence Q&A

What is OrthoSpace's primary product?

OrthoSpace's primary product is InSpace, an implantable, biodegradable balloon system designed to treat irreparable rotator cuff tears by reducing pain and improving range of motion.

When was OrthoSpace acquired and by whom?

OrthoSpace was acquired by Stryker Corporation in March 2019.

Which investors participated in OrthoSpace's December 2016 funding round?

In December 2016, OrthoSpace received funding from Triventures and HealthpointCapital.

What was a key milestone for OrthoSpace in March 2018?

In March 2018, OrthoSpace completed enrollment for its InSpace™ U.S. Pivotal Study, a significant step towards regulatory approval in the United States.

What was the outcome of OrthoSpace's InSpace study published in June 2017?

In June 2017, OrthoSpace announced the publication of positive results from an InSpace™ study, indicating favorable outcomes for its biodegradable balloon system.